GLP-1 receptor agonist use in patients with diabetes aims to mitigate cardiovascular kidney and metabolic risk.

FibroScan-aspartate aminotransferase may offer the highest sensitivity for ruling out at-risk metabolic dysfunction-associated steatohepatitis.

New guidelines for menopause treatment focus on hormone therapy and managing symptoms like hot flashes, sleep trouble, and depression.

Adding evolocumab to lipid-lowering therapy reduces all-cause mortality in high-risk patients without a history of myocardial infarction or stroke.

Among critically ill patients with acute kidney injury, intermittent hemodialysis as an initial treatment is not noninferior to CRRT.

Gossamer Bio has submitted a New Drug Application to the FDA seeking approval of seralutinib for pulmonary arterial hypertension (PAH).

Symptoms persist or become worse in more than a third of patients hospitalized due to heart failure, research shows.

Global myocarditis cases increased from 1990 to 2023, while age-standardized mortality and disability-adjusted life years saw significant declines.

There is an increased risk for incident MASLD associated with late-night eating, defined as eating after dinner or after bedtime.

Acute seizures occurring after pediatric ischemic stroke are strongly associated with an increased risk for subsequent poststroke epilepsy.

A single partial-body amyloid PET scan can detect major types of cardiac amyloidosis even in early, low-burden ATTR, researchers have found.

Post-hoc phase 2 data show coramitug induces an early, transient hsCRP rise followed by a sustained 52-week inflammatory reduction in ATTR-CM.